AI
COV

Axiom Investors’s COVIDIEN PLC COM SHS NEW (IRELAND) COV Stock Holding History

Axiom Investors’s Portfolio COV Stock Details COV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-392,850
Closed -$35.4M – 183
2014
Q2 		$35.4M Buy
392,850
+10,920
+3% +$817K 0.83% 51
2014
Q1 		$28.1M Buy
381,930
+73,820
+24% +$5.15M 0.67% 65
2013
Q4 		$21M Sell
308,110
-172,590
-36% -$11.2M 0.56% 67
2013
Q3 		$29.3M Buy
480,700
+95,150
+25% +$5.81M 0.94% 53
2013
Q2 		$19.6M Buy
+385,550
New +$22.3M 0.71% 59

Other funds holding COV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Axiom Investors's COV Position: Q3 2014 in Review

Axiom Investors sold out of COVIDIEN PLC COM SHS NEW (IRELAND) (COV) in Q3 2014, closing a stake of 392,850 shares — an estimated $35.4M sold.

Axiom Investors first reported a position in COV in Q2 2013 and held it in 5 quarters. The position peaked at $35.4M in Q2 2014. 720 funds tracked by Wall St. Rank hold COV as of Q3 2014.

  • Axiom Investors reported no remaining COVIDIEN PLC COM SHS NEW (IRELAND) position as of Q3 2014 after selling out during the quarter.
  • Axiom Investors sold 392,850 COVIDIEN PLC COM SHS NEW (IRELAND) shares in Q3 2014, an estimated $35.4M.
  • Axiom Investors first reported a position in COVIDIEN PLC COM SHS NEW (IRELAND) in Q2 2013 and held it in 5 quarters.
  • Axiom Investors's COVIDIEN PLC COM SHS NEW (IRELAND) position peaked at $35.4M in Q2 2014.
  • 720 funds tracked by Wall St. Rank held COVIDIEN PLC COM SHS NEW (IRELAND) as of Q3 2014.

Based on Axiom Investors's 13F filing for Q3 2014, filed 13 Nov 2014.